Mark J. Bishton, Rodney J. Hicks, David A. Westerman, Miles H. Prince, Max Wolf, John F. Seymour. A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin’s lymphoma following treatment with iodine-131-rituximab radio-immunotherapy. Haematologica 2008;93(5):789-790; https://doi.org/10.3324/haematol.12253.